Lazard Asset Management LLC Cytek Biosciences, Inc. Transaction History

Lazard Asset Management LLC

  • $68.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$9.71 - $15.86 $10,972 - $17,921
-1,130 Reduced 49.02%
1,175 $11,000
Q3 2022

Nov 14, 2022
SELL
$10.96 - $15.45 $46,580 - $65,662
-4,250 Reduced 64.84%
2,305 $33,000
Q2 2022

Aug 09, 2022
BUY
$7.41 - $11.56 $48,572 - $75,775
6,555 New
6,555 $70,000

Others Institutions Holding CTKB

# of Institutions
134
Shares Held
71.7M
Call Options Held
400
Put Options Held
0
View Full List

About Cytek Biosciences, Inc.

CTKB Quotes by TradingView
  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $851M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email